Welcome to the Life Sciences blog.

Here you will find articles and insights about life sciences and healthcare.

カテゴリーなし
August 3, 2017

R&D spend up, capital down makes for shorter runways for midmarket biotech companies
カテゴリーなし
August 1, 2017

HIV may be beatable using cancer’s new toolbox
カテゴリーなし
July 25, 2017

Cortellis: Notable life science mergers & acquisitions in Q2 2017
カテゴリーなし
July 19, 2017

Lung cancer – continued progress in personalized care
カテゴリーなし
July 18, 2017

DCAT Sharp Sourcing session focuses on best practices
カテゴリーなし
July 13, 2017

Checkpoint inhibitors: a cutting edge in oncology
カテゴリーなし
July 13, 2017

Utilization of specific biomarker roles within clinical trials
カテゴリーなし
June 22, 2017

FDA approval and regulation of medical devices: a primer
カテゴリーなし
June 13, 2017

When competitive intelligence is predictive rather than reactive, biopharma companies can grab the edge
カテゴリーなし
June 12, 2017

NGS, maybe, sort of, sometimes clinic ready
カテゴリーなし
June 6, 2017

Cortellis M&A Landscape: Notable mergers & acquisitions of Q1 2017
カテゴリーなし
May 31, 2017

Positive outlook for CDMOs at CPhI North America, but companies need to be ready for challenges
カテゴリーなし
May 25, 2017

DCAT Week ’17 session looks at emerging pharma market trends
カテゴリーなし
May 22, 2017

DCAT Week highlights pharma challenges, opportunities
カテゴリーなし
May 22, 2017

Advancing evidence-based indication prioritization to navigate disease segmentation landscape